Advertisement
| chemotherapy and immunotherapy guidelines and recommendations for practice: Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela M. Olsen, Kristine B. LeFebvre, Suzanne L. Walker, Elizabeth Prechtel Dunphy, 2022 Oncology nursing is a unique specialty that requires continuous learning to stay up to date on cancer pathophysiology, cutting-edge drugs, and the evidence-based management of cancer and cancer treatment-related toxicities. The Oncology Nursing Society's (ONS's) second edition of Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice provides nurses with the tools to understand how medications are used in cancer treatment, the effect of medication-related toxicities, and evidence-based recommendations to manage and treat these toxicities. This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive drug tables in the book provide nurses with tips for managing patients receiving these drugs. The expansion of oral antineoplastic therapies, alone or in combination with infusion therapy, requires that nurses review a patient's complete cancer treatment plan and consider the side effects, toxicities, and adherence to oral drugs to ensure patient tolerance and efficacy. This second edition has seen content expanded on the topic of genomics as we move forward in the world of personalized oncology. Health equity is approached with information discussing financial distress, cultural disparities, and health literacy. The latest guidelines and recommendations for treatment, symptom management, and survivorship have been integrated into this new text. This edition features a QR code, provided with the purchase of this book, to download quarterly drug updates. You will see new evidence related to many aspects of cancer nursing care incorporated into this edition, such as hypersensitivity response, safe handling of hazardous drugs, and more. The editors want to thank all of the contributors to this edition who worked tirelessly, despite a pandemic, to make this new edition a reality. This work builds on the knowledge of many generations of oncology nurses and has been used nationally and internationally to guide oncology nursing practice. We are proud to continue to serve oncology nurses worldwide with an essential resource to guide their practice-- |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Guide to Immunotherapy Suzanne L. Walker, Elizabeth Prechtel Dunphy, 2018-10 |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Chemotherapy and Biotherapy Guidelines and Recommendations for Practice Martha Polovich, MiKaela M. Olsen, Kristine B. LeFebvre, 2014 Order your copy of the fourth edition of the best-selling resource used by more than 101,000 healthcare professionals since 2009 and keep up-to-date on the latest chemotherapy, biotherapy, and targeted agents. This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your specialty. You'll find that this latest edition incorporates a number of significant changes. To help you find the content and information that you need quickly and easily, the text has been reorganized and is now divided into 11 chapters ranging from an overview of cancer and cancer treatment and principles of antineoplastic therapy to post-treatment care and competencies in chemotherapy administration. Patient education information has also been expanded in the new edition to emphasize importance of education in patient care. And, finally, look for new information on chemotherapy sequencing and updates on the nursing management of treatment side effects.As with previous editions, the guidelines strives to bring you the latest details on approved drugs, standards of practice, and available evidence. Make sure to update your library with this latest edition of one of the most trusted and widely used resources for practicing oncology nurses. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Clinical Guide to Antineoplastic Therapy Mary Magee Gullatte, 2014 Get the latest information on antineoplastic use and patient care when you purchase your copy of the essential chemotherapy resource for cancer-care professionals. Newly updated, revised, and expanded, the third edition of the Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook serves as an up-to-date reference for clinicians at every level from students and novices to the most seasoned nurses and other healthcare professionals involved in the care of patients receiving chemotherapy. Edited by Mary Magee Gullatte, this comprehensive guide features chapters on the fundamentals of antineoplastic therapy, commonly used regimens for specific cancers, clinical trials, reimbursement for chemotherapy, botanicals and other complementary and alternative therapies, vascular access devices, and symptom management, as well as an easy-to-use A Z guide of more than 150 chemotherapy, biotherapy, and hormonal therapy agents. New to this edition are chapters on patient navigati |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Cancer Chemotherapy, Immunotherapy, and Biotherapy Bruce Chabner, Dan Louis Longo, 2018 Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Thoroughly revised and reformatted, the sixth edition of Cancer Chemotherapy, Immunotherapy and Biotherapy reflects recent significant changes in cancer treatment. This newly streamlined edition contains full-color illustrations, more tables for quick reference, and new immunotherapy and molecular targeted therapy content that brings you fully up to date with the state of the art in all current cancer therapies. Provides thorough, comprehensive coverage of the scientific and clinical aspects of immunotherapy, biotherapy, and chemotherapy. Includes significantly expanded information on immunotherapy and molecular targeted therapy, as well as the latest information on all drugs and biological agents--their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. Features a new, full-color format, a newly streamlined presentation. and more tables and figures throughout for quick access to high-yield information. Explains the rationale for use of drugs in specific schedules and combinations and offers guidelines for dose adjustment in specific situations. Enhance Your eBook Reading Experience Read directly on your preferred device(s), such as computer, tablet, or smartphone. Easily convert to audiobook, powering your content with natural language text-to-speech. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Chemotherapy and Immunotherapy in Urologic Oncology Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi, 2020-09-29 This book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book’s chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Cancer Chemotherapy and Biotherapy Bruce A. Chabner, Dan L. Longo, 2011-12-07 Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Core Curriculum for Oncology Nursing Joanne Itano, Karen N. Taoka, 2005-01-01 Published in collaboration with the ONS, this text is the definitive source for concepts and practices in oncology nursing and can be used for orientation of nurses to oncology, inservice and continuing education programs for practicing nurses, a basis for curriculum development in graduate programs, and as a review tool for certification. Based on the blueprint of the certification examination by the ONCC (Oncology Nursing Certification Corporation), the book is in outline format to help readers focus on the most important information. Instructor resources available; contact your sales representative for details. Covers the entire scope of the specialty ensuring comprehensive coverage Outline format helps the reader focus on the most important information Effective guide for teaching and learning for in-service, continuing education, and academic programs Powerful study tool for the ONCC certification exam Tables and figures illustrate complex concepts * Entirely revised, updated, and expanded to reflect the current state of oncology nursing practice. * Expanded pain management content. * New content on nonpharmacologic interventions (e.g. heat massage, imagery). * New content on alternative therapies. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Oxford Textbook of Oncology David J. Kerr, Daniel G. Haller, Cornelis J. H. van de Velde, Michael Baumann, 2016-01-28 Written and edited by internationally recognised leaders in the field, the new edition of the Oxford Textbook of Oncology has been fully revised and updated, taking into consideration the advancements in each of the major therapeutic areas, and representing the multidisciplinary management of cancer. Structured in six sections, the book provides an accessible scientific basis to the key topics of oncology, examining how cancer cells grow and function, as well as discussing the aetiology of cancer, and the general principles governing modern approaches to oncology treatment. The book examines the challenges presented by the treatment of cancer on a larger scale within population groups, and the importance of recognising and supporting the needs of individual patients, both during and after treatment. A series of disease-oriented, case-based chapters, ranging from acute leukaemia to colon cancer, highlight the various approaches available for managing the cancer patient, including the translational application of cancer science in order to personalise treatment. The advice imparted in these cases has relevance worldwide, and reflects a modern approach to cancer care. The Oxford Textbook of Oncology provides a comprehensive account of the multiple aspects of best practice in the discipline, making it an indispensable resource for oncologists of all grades and subspecialty interests. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Cancer Immunotherapy Principles and Practice Lisa H. Butterfield, Howard L. Kaufman, Francesco M. Marincola, 2017 Part 1: Intratumoral Signatures Associated With Immune Responsiveness |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Malignant Pleural Mesothelioma Ken O'Byrne, Valerie W. Rusch, 2006 This book provides health professionals and scientists with a comprehensive overview of the mesothelioma - an asbestos induced malignancy. It includes chapters on epidemology, diagnosis, histopathology, radiology, surgery, chemotherapy, immune therapy, and radiotherapy as well as the molecular biology and future therapies. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Nutritional Oncology David Heber, Zhaoping Li, Vay Liang, 2021-08-23 Comprehensive treatment of all aspects of nutrition and cancer, including prevention, response to treatment, avoidance of relapse and promotion of quality of life for cancer survivors. Examines alternative medicines and botanical dietary supplements and identifies hypotheses for future research based on science. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: 2020-2021 Oncology Nursing Drug Handbook Gail M. Wilkes, Margaret Barton-Burke, 2019-11-20 Written especially for nurses caring for patients with cancer, the 2020-2021 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2018 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Palliative Care in Oncology Bernd Alt-Epping, Friedemann Nauck, 2015-03-26 Palliative care provides comprehensive support for severely affected patients with any life-limiting or life-threatening diagnosis. To do this effectively, it requires a disease-specific approach as the patients’ needs and clinical context will vary depending on the underlying diagnosis. Experts in the field of palliative care and oncology describe in detail the needs of patients with advanced cancer in comparison to those with non-cancer disease and also identify the requirements of patients with different cancer entities. Basic principles of symptom control are explained, with careful attention to therapy for pain associated with either the cancer or its treatment and to symptom-guided antineoplastic therapy. Complex therapeutic strategies for palliative cancer patients are highlighted that involve both cancer- and symptom-directed options and address a range of therapeutic aims. Issues relating to drug use in palliative cancer care are fully explored, and a separate section is devoted to care in the final phase. A range of organizational and policy issues are also discussed, and the book concludes by considering likely future developments in palliative care for cancer patients. Palliative Care in Oncology will be of particular interest to palliative care physicians who are interested in broadening the scope of their disease-specific knowledge, as well as to oncologists who wish to learn more about modern palliative care concepts relevant to their day-to-day work with cancer patients. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Chemotherapy and Biotherapy Guidelines and Recommendations for Practice Martha Polovich, Julie M. Whitford, MiKaela M. Olsen, 2009 |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Immunotherapy of Hepatocellular Carcinoma Tim F. Greten, 2018-08-22 In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing interest in the community due to first promising results obtained in early clinical trials. Hepatocellular carcinoma (HCC) is the third most common cause of cancer related death in the United States. Treatment options are limited. Viral hepatitis is one of the major risk factors for HCC, which represents a typical “inflammation-induced” cancer. Immune-based treatment approaches have revolutionized oncology in recent years. Various treatment strategies have received FDA approval including dendritic cell vaccination, for prostate cancer as well as immune checkpoint inhibition targeting the CTLA4 or the PD1/PDL1 axis in melanoma, lung, and kidney cancer. Additionally, cell based therapies (adoptive T cell therapy, CAR T cells and TCR transduced T cells) have demonstrated significant efficacy in patients with B cell malignancies and melanoma. Immune checkpoint inhibitors in particular have generated enormous excitement across the entire field of oncology, providing a significant benefit to a minority of patients. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Safe Handling of Hazardous Drugs Martha Polovich, MiKaela M. Olsen, 2017-11 |
| chemotherapy and immunotherapy guidelines and recommendations for practice: SITC’s Guide to Managing Immunotherapy Toxicity Marc S. Ernstoff, MD, Igor Puzanov, MD, MSCI, FACP, Caroline Robert, MD, PhD, Adi M. Diab, MD, Peter M. Hersey, MD, PhD, 2019-03-15 The Society for Immunotherapy of Cancer's handbook,SITC’s Guide to Managing Immunotherapy Toxicity, is a practical reference to managing side effects associated with FDA-approved cancer immunotherapy drugs. Separated into two parts, Part I contains chapter-based overviews of immune checkpoint inhibitors in the clinic, starting with anti-CTLA4 agents, anti-PD1/PD-L1 agents, and approved immunotherapeutic combinations. These chapters cover relevant mechanisms of action, indications, and toxicities seen while combating early, advanced, and metastatic stages in cancer patients. Part II is structured by common and uncommon toxicities that affect major organ sites throughout the body. It begins with a general summary of principles and management options followed by chapters focusing on specific toxicities such as rash and mucosal irritation, muscle and joint toxicity, diarrhea and colitis, pneumonitis, endocrine toxicities, neurological toxicities, cardiac toxicity, renal toxicity, hematologic toxicity, and ocular toxicities. Each chapter provides guidance on how to assess and treat the toxicity and how to support the patient through acute and chronic effects with detailed summary tables for quick reference. Part II concludes with chapters covering management of special patient populations, including patients with autoimmune disease and geriatric patients, treatment and management of fatigue, and a final chapter dedicated to cost effectiveness and the toll of financial toxicity on patients and caregivers. With chapters written by world-recognized leaders in the immuno-oncology field, this text provides thorough coverage of the toxicity and management of adverse effects for immune checkpoint inhibitors. It is an indispensable resource for clinical oncologists, emergency physicians, hospitalists and other medical practitioners in both the hospital and community clinic settings, especially as the use of immune checkpoint inhibitors becomes a fixture in oncology care. Key Features: Outlines strategies for treating high-risk patients facing an acute or chronic side effect to immunotherapy Provides numerous tables that condense and highlight pertinent information for quick reference Describes the various clinical presentations and toxic reactions caused by immunotherapy Purchase includes access to the eBook for use on most mobile devices or computer |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Understanding and Managing Oncologic Emergencies Marcelle Kaplan, 2018 Thoroughly updated and expanded, the third edition of Understanding and Managing Oncologic Emergencies: A Resource for Nurses is a comprehensive yet practical guide to understanding and managing oncologic emergencies from the nursing perspective. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Telephone Triage for Oncology Nurses Margaret Hickey, Susan Newton, 2005 |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Life Over Cancer Keith Block, 2009-04-21 Dr. Keith Block is at the global vanguard of innovative cancer care. As medical director of the Block Center for Integrative Cancer Treatment in Evanston, Illinois, he has treated thousands of patients who have lived long, full lives beyond their original prognoses. Now he has distilled almost thirty years of experience into the first book that gives patients a systematic, research-based plan for developing the physical and emotional vitality they need to meet the demands of treatment and recovery. Based on a profound understanding of how body and mind can work together to defeat disease, this groundbreaking book offers: • Innovative approaches to conventional treatments, such as “chronotherapy”–chemotherapy timed to patients’ unique circadian rhythms for enhanced effectiveness and reduced toxicity • Dietary choices that make the biochemical environment hostile to cancer growth and recurrence, and strengthen the immune system’s ability to attack remaining cancer cells • Precise supplement protocols to tame treatment side effects, relieve disease-related symptoms, and modify processes like inflammation and glycemia that can fuel cancer if left untreated • A new paradigm for exercise and stress reduction that restores your strength, reduces anxiety and depression, and supports the body’s own ability to heal • A complete program for remission maintenance–a proactive plan to make sure the cancer never returns Also included are “quick-start” maps to help you find the information you need right now and many case histories that will support and inspire you. Encouraging, compassionate, and authoritative, Life over Cancer is the guide patients everywhere have been waiting for. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Pocket Oncology Alexander Drilon, Michael Postow, 2014 Pocket Oncology, developed and edited by oncologists at Memorial Sloan-Kettering Cancer Center, is a simple, yet comprehensive, review of basic principles of cancer management. Prepared in the style and format of books in the popular Pocket Notebook series, Pocket Oncology is intended as a quick reference presented in easy to read bulleted text, and using diagrams and charts where appropriate. Each oncologic disease is presented on two facing pages that review initial clinical presentation, pathophysiology, staging, current standard of care treatments, and active areas of current research. Edited by Alexander Drilon and Michael Postow, the content of the book has been written by medical oncology fellows and each disease entity has been authoritatively reviewed by an oncologist with specific expertise in each subspecialty of oncology. Features: -simple, comprehensive, review of basic principles of oncology in easy to read bulleted text, using diagrams and charts where appropriate. -its small size makes it easy to carry the pocket of a lab coat for quick reference to information while in the hospital or oncology clinic. -perfect for medical students, residents, fellows, physician assistants, and nurses who perform daily oncologic care. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Putting Evidence Into Practice Linda H. Eaton, Janelle M. Tipton, Margaret Irwin, 2011 Supplement to Putting Evidence into Practice: Improving Oncology Patient Outcomes (Eaton and Tipton, 2009). |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Cancer Pharmacology and Pharmacotherapy Review Anthony J. Perissinotti, PharmD, BCOP, Bernard L. Marini, PharmD, 2016-03-14 Cancer Pharmacology and Pharmacotherapy Review is the first book devoted entirely to providing the ‘must-know’ facts on each cancer agent—including their pharmacokinetics, FDA-approved indications, toxicity, interactions, and other important information that is commonly found on board examinations and essential for any clinician or practitioner to review. The authors, an oncologist and two pharmacists, have developed a handy question-and-answer format to present the material in digestible bursts. As the pharmacology section continues to represent a major portion of the medical oncology exam and a key component on oncology MOC exams, this portable study guide will help prepare anyone looking to fine-tune their knowledge on cancer drugs before the test. Not to mention, with recent advancements in the field of cancer treatment, it has become more cumbersome to recall and maintain essential knowledge of every cancer therapeutic—making this book not only an exam resource but also a handy quick reference for oncologists and pharmacists alike. KEY FEATURES Conveniently organized and arranged by drug class and subtypes for easier recall and classification Includes proper dosage adjustments to account for liver and kidney dysfunction Features tables throughout that provide quick reference regarding FDA-approved medications Simplified diagrams and illustrations facilitate the pharmacokinetic processes |
| chemotherapy and immunotherapy guidelines and recommendations for practice: OCN Secrets Ocn Exam Secrets Test Prep Team, 2013-02 ***Includes Practice Test Questions*** OCN Exam Secrets helps you ace the ONCC Oncology Certified Nurse Exam, without weeks and months of endless studying. Our comprehensive OCN Exam Secrets study guide is written by our exam experts, who painstakingly researched every topic and concept that you need to know to ace your test. Our original research reveals specific weaknesses that you can exploit to increase your exam score more than you've ever imagined. OCN Exam Secrets includes: The 5 Secret Keys to ONCC Exam Success: Time is Your Greatest Enemy, Guessing is Not Guesswork, Practice Smarter, Not Harder, Prepare, Don't Procrastinate, Test Yourself; A comprehensive General Strategy review including: Make Predictions, Answer the Question, Benchmark, Valid Information, Avoid Fact Traps, Milk the Question, The Trap of Familiarity, Eliminate Answers, Tough Questions, Brainstorm, Read Carefully, Face Value, Prefixes, Hedge Phrases, Switchback Words, New Information, Time Management, Contextual Clues, Don't Panic, Pace Yourself, Answer Selection, Check Your Work, Beware of Directly Quoted Answers, Slang, Extreme Statements, Answer Choice Families; Comprehensive sections including: Growth and Development, Family Systems Theory, Nursing Assessment and Intervention in Children, Psychosocial Dimensions of Care, Psychosocial Adaptation, Spiritual Beliefs/Rituals, Social Relationships, Parenting, Cultural Diversity, Common Fears and Coping Strategies, Hospitalization, Epidemiology, Acute Lymphoblastic Leukemia (ALL), Juvenile Myelomonocytic Leukemia (JMML), Pathophysiology of Leukemia, Hematologic Changes, Non-Hodgkin Lymphoma, CNS Tumors, Neuroblastoma, Renal Tumors, Carcinogenesis, Chemotherapy, Biotherapy & Gene Therapy, Radiation Therapy, Surgery, Supportive Care Measures, Clinical Trials in Pediatric Oncology, Informed Consent, Treatment Protocols, Hodgkin Disease (HD), Retinoblastoma, Symptom Management, and much more... |
| chemotherapy and immunotherapy guidelines and recommendations for practice: CDC Yellow Book 2018: Health Information for International Travel Centers for Disease Control and Prevention CDC, 2017-04-17 THE ESSENTIAL WORK IN TRAVEL MEDICINE -- NOW COMPLETELY UPDATED FOR 2018 As unprecedented numbers of travelers cross international borders each day, the need for up-to-date, practical information about the health challenges posed by travel has never been greater. For both international travelers and the health professionals who care for them, the CDC Yellow Book 2018: Health Information for International Travel is the definitive guide to staying safe and healthy anywhere in the world. The fully revised and updated 2018 edition codifies the U.S. government's most current health guidelines and information for international travelers, including pretravel vaccine recommendations, destination-specific health advice, and easy-to-reference maps, tables, and charts. The 2018 Yellow Book also addresses the needs of specific types of travelers, with dedicated sections on: · Precautions for pregnant travelers, immunocompromised travelers, and travelers with disabilities · Special considerations for newly arrived adoptees, immigrants, and refugees · Practical tips for last-minute or resource-limited travelers · Advice for air crews, humanitarian workers, missionaries, and others who provide care and support overseas Authored by a team of the world's most esteemed travel medicine experts, the Yellow Book is an essential resource for travelers -- and the clinicians overseeing their care -- at home and abroad. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Oncology Nutrition for Clinical Practice Anne Coble Voss, Valaree Williams, 2021 A comprehensive reference for professionals providing up-to-date oncology nutrition practice recommendations, the latest nutrition assessment tools, current knowledge, and support and resources-- |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Dermatologic Principles and Practice in Oncology Mario E. Lacouture, 2013-11-26 The first book focusing specifically on frequent and frequently disabling side effects involving the skin, hair and nails in cancer patients According to the World Health Organization, there are approximately thirty million people living with a diagnosis of cancer – the majority of whom will receive surgery, systemic therapy, and/or radiation, and who will suffer from dermatologic adverse events. Dermatologists and oncologists are only beginning to grapple with these events, which pose serious quality-of-life issues with so many patients, and will become more prevalent as survival rates improve, thanks in part to new cancer treatments and drug regimens. Concentrating on a topic that has only been briefly touched upon by other texts, this book offers a focused perspective on the clinical presentation, underlying pathophysiologic mechanisms, and management of skin, hair, and nail conditions for oncologists, dermatologists, and allied practitioners. Dermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients: • Covers in detail the dermatologic adverse events of oncologic therapies, clinical presentations, and treatment recommendations • Enables dermatologists and other practitioners to significantly improve the care of patients with cancer • Addresses the dermatologic adverse events of cancer therapies used globally, of which a large number are found in developing countries • Emphasizes prophylactic measures – based on treatments used and type of cancer – to prevent the appearance of adverse events • Provides built-in discussions on patient education for practical counseling during therapies • Offers rapid-reference sections on topical dermatology drugs The first book to present dermatologic conditions in cancer patients and survivors in a uniform and in-depth manner, Dermatologic Principles and Practice in Oncology is ideal for oncologists, oncology nurses, and dermatologists who wish to take better care of those with adverse skin, hair, and nail conditions. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Physicians' Cancer Chemotherapy Drug Manual Edward Chu, Vincent T. DeVita, 2007 Includes free CD-ROM! Completely revised and updated for 2007, this practical handbook is an up-to-date guide to all aspects of cancer chemotherapy. The book provides a comprehensive, easy to use catalogue of over 100 drugs-both on- and off-label-commonly used in cancer treatment, including several new agents (recently or about to be FDA approved). A section on Common Chemotherapy Regimens provides a quick reference to management of specific cancers, arranged alphabetically. A comprehensively revised introductory chapter on Principles of Chemotherapy offers a concise, current overview of the field. Special features include: Special chapter profiling anti-emetic drugs Diagrams of drug structures and pathways Complete discussion of clinical pharmacology, indications, and dosages Coverage of toxicity and interactions Separate chapter on chemotherapy regimens for specific cancers Overview of basic principles of cancer drug therapy Easy to load and use CD-ROM version PDA version of Physicians' Cancer Chemotherapy Drug Manual also available! |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Cancer-Associated Thrombosis Alok A. Khorana, Charles W. Francis, 2007-09-26 Showcasing the expertise of top-tier specialists who contributed to the newly released guidelines for the care of thrombosis in cancer patients, this exciting guide was written and edited by members of the American Society of Clinical Oncology panel, (ASCO), on the prevention and treatment of cancer-associated thrombosis, among others, and provides |
| chemotherapy and immunotherapy guidelines and recommendations for practice: ESMO Handbook of Oncological Emergencies Paris A Kosmidis, Dirk Schrijvers, Fabrice Andre, Sylvie Rottey, 2005-06-01 Young medical oncologists, who may often find themselves faced by major complications caused by cancer or by cancer treatment, will welcome this handbook as a highly useful tool to develop their knowledge and skills in the area. Initiated by the European Society for Medical Oncology’s (ESMO) Young Medical Oncologists Working Group, this succinct text has been written by a distinguished team of young medical oncologists and senior figures in the field, and is designed to provide oncologists with a secure practical grounding in the correct courses of action to follow in an emergency. The key topics covered include: * cardiovascular complications * neurological complications * renal and urologic complications * metabolic complications * respiratory complications * gastro-intestinal complications * hematologic complications * cancer pain. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Chemotherapy and Radiation For Dummies Alan P. Lyss, Humberto Fagundes, Patricia Corrigan, 2011-05-18 An informative, compassionate guide for cancer patients and their loved ones Each year, more than 1 million people get treated for cancer, and most of these will undergo chemotherapy, radiation therapy, or both. This reassuring, optimistic guide helps people get a handle on treatment options and explains in plain English how chemotherapy and radiation therapy really work. It offers detailed advice on how to alleviate and cope with side effects-which range from hair loss to nausea to anemia-and describes how good nutrition, meditation, support groups, and other techniques and resources can help in the recovery process. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: The European Blood and Marrow Transplantation Textbook for Nurses Michelle Kenyon, Aleksandra Babic, 2018-03-14 This book is open access under a CC BY 4.0 license. This textbook, endorsed by the European Society for Blood and Marrow Transplantation (EBMT), provides adult and paediatric nurses with a full and informative guide covering all aspects of transplant nursing, from basic principles to advanced concepts. It takes the reader on a journey through the history of transplant nursing, including essential and progressive elements to help nurses improve their knowledge and benefit the patient experience, as well as a comprehensive introduction to research and auditing methods. This new volume specifically intended for nurses, complements the ESH-EBMT reference title, a popular educational resource originally developed in 2003 for physicians to accompany an annual training course also serving as an educational tool in its own right. This title is designed to develop the knowledge of nurses in transplantation. It is the first book of its kind specifically targeted at nurses in this specialist field and acknowledges the valuable contribution that nursing makes in this area. This volume presents information that is essential for the education of nurses new to transplantation, while also offering a valuable resource for more experienced nurses who wish to update their knowledge. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Core Curriculum for Oncology Nursing - E-Book Oncology Nursing Society, Jeannine M. Brant, Diane G. Cope, Marlon Garzo Saría, 2023-06-30 - NEW! Updated content throughout reflects the 2022 OCN® Examination blueprint, along with the latest national and international guidelines and the most current research evidence. - NEW! A Myelofibrosis chapter is added to address this important cancer type, and a Social Determinants of Health and Financial Toxicity chapter addresses the cost of cancer treatment and financial burden of cancer treatment on patients and families. - NEW! COVID-19–related content reflects the impact of the ongoing pandemic, including differential diagnoses for pulmonary symptoms and the impact of delayed cancer diagnosis and treatment. - NEW! Updated emphases mirror those of the American Association of Colleges of Nursing 2021 Essentials as well as the recommendations of the 2020-2030 Future of Nursing report. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: ICD-10-CM Official Guidelines for Coding and Reporting - FY 2021 (October 1, 2020 - September 30, 2021) Department Of Health And Human Services, 2020-09-06 These guidelines have been approved by the four organizations that make up the Cooperating Parties for the ICD-10-CM: the American Hospital Association (AHA), the American Health Information Management Association (AHIMA), CMS, and NCHS. These guidelines are a set of rules that have been developed to accompany and complement the official conventions and instructions provided within the ICD-10-CM itself. The instructions and conventions of the classification take precedence over guidelines. These guidelines are based on the coding and sequencing instructions in the Tabular List and Alphabetic Index of ICD-10-CM, but provide additional instruction. Adherence to these guidelines when assigning ICD-10-CM diagnosis codes is required under the Health Insurance Portability and Accountability Act (HIPAA). The diagnosis codes (Tabular List and Alphabetic Index) have been adopted under HIPAA for all healthcare settings. A joint effort between the healthcare provider and the coder is essential to achieve complete and accurate documentation, code assignment, and reporting of diagnoses and procedures. These guidelines have been developed to assist both the healthcare provider and the coder in identifying those diagnoses that are to be reported. The importance of consistent, complete documentation in the medical record cannot be overemphasized. Without such documentation accurate coding cannot be achieved. The entire record should be reviewed to determine the specific reason for the encounter and the conditions treated. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Study Guide for the Core Curriculum for Oncology Nursing Suzanne M. Mahon, 2005 Published in collaboration with the ONS, this Study Guide is a must-have for those who are taking the certification exam. The chapters parallel those presented in the Core Curriculum for Oncology Nursing, 4e. The number of questions in each chapter will correspond with the percentage of questions on that particular topic included in the certification exam. Answers and rationales for correct and incorrect responses are listed at the end of each chapter. The book also includes an updated bibliography for each subject. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Childhood Cancer and Functional Impacts Across the Care Continuum National Academies of Sciences Engineering and Medicine, Health and Medicine Division, Board on Health Care Services, Committee on Childhood Cancers and Disability, 2021-09-09 Since the late 1960s, the survival rate in children and adolescents diagnosed with cancer has steadily improved, with a corresponding decline in the cancer-specific death rate. Although the improvements in survival are encouraging, they have come at the cost of acute, chronic, and late adverse effects precipitated by the toxicities associated with the individual or combined use of different types of treatment (e.g., surgery, radiation, chemotherapy). In some cases, the impairments resulting from cancer and its treatment are severe enough to qualify a child for U.S. Social Security Administration disability benefits. At the request of Social Security Administration, Childhood Cancer and Functional Impacts Across the Care Continuum provides current information and findings and conclusions regarding the diagnosis, treatment, and prognosis of selected childhood cancers, including different types of malignant solid tumors, and the effect of those cancers on childrenâ (TM)s health and functional capacity, including the relative levels of functional limitation typically associated with the cancers and their treatment. This report also provides a summary of selected treatments currently being studied in clinical trials and identifies any limitations on the availability of these treatments, such as whether treatments are available only in certain geographic areas. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: International Manual of Oncology Practice Ramon Andrade De Mello, Giannis Mountzios, Álvaro A. Tavares, 2020-10-30 Cancer is a very aggressive disease and currently it has been considered a challenge to oncologists and cancer patients worldwide. Nowadays, several therapeutic strategies had improved toward last decades. Surgery is many times still the best curative treatment, mainly in early stage disease. However, Radiotherapy and chemotherapy acquired a main role in this scenario. Target therapies were introduced for medical oncology practice and are demonstrating a hallmark of a new era in cancer treatment. More recently, immunotherapy has been considered the novel cornerstone in cancer treatment. The 2nd edition of the International Manual of Oncology Practice (iMOP) emerged after the great success of the iMOP 1st edition as a reference for medical oncologists and medical residents in the field. In this edition, several chapters were revised and its addresses from the molecular issues of cancer sciences to the clinical practice in medical oncology. In addition, multiple choice questions and clinical cases were included in the main chapters in order to improve the reader learning. The book focuses systemic treatments in many areas of medical oncology, such as breast cancer, gastrointestinal, thoracic, urological oncology, head and neck tumors, bone tumors, sarcomas and palliative care. The topics herein discussed will provide the readers a step forward in the medical oncology practice understanding and give facilities for help in cancer patient treatments. |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Comparative Oncology Alecsandru Ioan Baba, Cornel Cătoi, 2007 |
| chemotherapy and immunotherapy guidelines and recommendations for practice: Red Book 2021 David W. Kimberlin, Elizabeth Barnett, Ruth Lynfield, Mark H. Sawyer, 2021-05-15 The AAP's authoritative guide on preventing, recognizing, and treating more than 200 childhood infectious diseases. Developed by the AAP's Committee on Infectious Diseases as well as the expertise of the CDC, the FDA, and hundreds of physician contributors. |
Chemotherapy and Immunotherapy Guidelines and …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
CHAPTER 1 Professional Practice Considerations
Verbal orders for chemotherapy, targeted therapy, and immunotherapy medications are not permitted, except to hold or stop drugs (ISMP, 2017a; Neuss et al., 2016). Text messaging of …
Management of Immune-Related Adverse Events in Patients …
Nov 1, 2021 · This clinical practice guideline focuses on one overarching clinical question: How should clinicians manage immune-mediated adverse events (AEs) in adult patients with …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela Olsen,Kristine LeFebvre,Suzanne Walker,Elizabeth Prechtel Dunphy,2025-03-14 …
Ons Chemotherapy And Immunotherapy Guidelines .pdf
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy,2022 Oncology …
Chemotherapy And Biotherapy Guidelines And …
This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive …
Chemotherapy And Immunotherapy Guidelines And …
This comprehensive guide provides valuable insights into chemotherapy and immunotherapy guidelines and recommendations for practice. By staying updated on the latest advancements …
Chemotherapy And Immunotherapy Guidelines And …
This comprehensive guide delves into the current guidelines and recommendations for the practice of chemotherapy and immunotherapy, two cornerstones of modern cancer treatment. …
Oncology Nursing Society Chemotherapy and Immunotherapy …
Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Errata The following changes have been made in the e-book and …
ACUTE ONCOLOGY INITIAL MANAGEMENT GUIDELINES
Guidelines for the initial management of adult patients who have a cancer diagnosis, and present as an emergency or unplanned admission with a complication of their disease or cancer …
Oncology Nursing Society Chemotherapy and Immunotherapy …
Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines ...
Education of the Nurse Who Administers and Cares for the …
Chemotherapy and Biotherapy: Fundamentals of Administration provides the essential information to best prepare all nurses to safely administer chemotherapy and biotherapy.
Good Practice Guideline for Immuno-Oncology Medicines
These guidelines have been developed by Mr Steve Williamson (representing the British Oncology Pharmacy Association), Dr Ruth Board (representing the Royal College of …
Chemotherapy And Biotherapy Guidelines And …
This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your …
Chemotherapy And Biotherapy Guidelines And …
This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive …
Society for Immunotherapy of Cancer (SITC) clinical practice …
With the goal of improving patient care by providing guidance to the oncology community, the Society for Immunotherapy of Cancer (SITC) convened a panel of experts to develop this …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy And Biotherapy Guidelines And Recommendations For Practice Offers a vast collection of books, some of which are available for free as PDF downloads, particularly older …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy,2022 Oncology …
Chemotherapy And Biotherapy Guidelines And …
Cancer treatment continues to evolve, with chemotherapy and biotherapy playing pivotal roles. This article provides healthcare professionals with an updated overview of guidelines and …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Biotherapy Guidelines and Recommendations for Practice Martha Polovich,MiKaela M. Olsen,Kristine B. LeFebvre,2014 Order your copy of the fourth edition of …
Chemotherapy and Immunotherapy Guidelines and …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
CHAPTER 1 Professional Practice Considerations
Verbal orders for chemotherapy, targeted therapy, and immunotherapy medications are not permitted, except to hold or stop drugs (ISMP, 2017a; Neuss et al., 2016). Text messaging of …
Management of Immune-Related Adverse Events in …
Nov 1, 2021 · This clinical practice guideline focuses on one overarching clinical question: How should clinicians manage immune-mediated adverse events (AEs) in adult patients with …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela Olsen,Kristine LeFebvre,Suzanne Walker,Elizabeth Prechtel Dunphy,2025-03-14 …
Ons Chemotherapy And Immunotherapy Guidelines .pdf
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy,2022 Oncology …
Chemotherapy And Biotherapy Guidelines And …
This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive …
Chemotherapy And Immunotherapy Guidelines And …
This comprehensive guide provides valuable insights into chemotherapy and immunotherapy guidelines and recommendations for practice. By staying updated on the latest advancements …
Chemotherapy And Immunotherapy Guidelines And …
This comprehensive guide delves into the current guidelines and recommendations for the practice of chemotherapy and immunotherapy, two cornerstones of modern cancer treatment. …
Oncology Nursing Society Chemotherapy and …
Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (Second Edition) Errata The following changes have been made in the e-book and …
ACUTE ONCOLOGY INITIAL MANAGEMENT GUIDELINES
Guidelines for the initial management of adult patients who have a cancer diagnosis, and present as an emergency or unplanned admission with a complication of their disease or cancer …
Oncology Nursing Society Chemotherapy and …
Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice Oncology Nursing Society Chemotherapy and Immunotherapy Guidelines ...
Education of the Nurse Who Administers and Cares for the …
Chemotherapy and Biotherapy: Fundamentals of Administration provides the essential information to best prepare all nurses to safely administer chemotherapy and biotherapy.
Good Practice Guideline for Immuno-Oncology Medicines
These guidelines have been developed by Mr Steve Williamson (representing the British Oncology Pharmacy Association), Dr Ruth Board (representing the Royal College of …
Chemotherapy And Biotherapy Guidelines And …
This new edition of the Chemotherapy and Biotherapy Guidelines and Recommendations for Practice has been revised and updated to reflect the current procedures and practices in your …
Chemotherapy And Biotherapy Guidelines And …
This edition features many new cancer therapies approved since the 2019 publication. Each drug is categorized as chemotherapy, hormone, targeted, or immunotherapy agents. Extensive …
Society for Immunotherapy of Cancer (SITC) clinical practice …
With the goal of improving patient care by providing guidance to the oncology community, the Society for Immunotherapy of Cancer (SITC) convened a panel of experts to develop this …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy And Biotherapy Guidelines And Recommendations For Practice Offers a vast collection of books, some of which are available for free as PDF downloads, particularly older …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice MiKaela M. Olsen,Kristine B. LeFebvre,Suzanne L. Walker,Elizabeth Prechtel Dunphy,2022 Oncology …
Chemotherapy And Biotherapy Guidelines And …
Cancer treatment continues to evolve, with chemotherapy and biotherapy playing pivotal roles. This article provides healthcare professionals with an updated overview of guidelines and …
Chemotherapy And Biotherapy Guidelines And …
Chemotherapy and Biotherapy Guidelines and Recommendations for Practice Martha Polovich,MiKaela M. Olsen,Kristine B. LeFebvre,2014 Order your copy of the fourth edition of …
